Federal prosecutors have charged Indivior with engaging in a multibillion-dollar fraudulent scheme to increase prescriptions of Suboxone Film, a medicine used to treat addiction to opioid and narcotics.
In an indictment filed on Wednesday, the Justice Department alleged the drug maker deceived doctors and payers into believing the medicine was safer and less prone to diversion and abuse than other such treatments, although the company lacked any scientific evidence to support those claims. The indictment also claimed the company used a telephone and Internet program to connect patients struggling with addiction to doctors who were inappropriately prescribing opioids and at high rates.
About the Author Reprints
